Search details
1.
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Mod Pathol
; 27(6): 906-15, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24309322
2.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 26(4): 822-825, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25814651
3.
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Int J Radiat Oncol Biol Phys
; 68(2): 334-40, 2007 Jun 01.
Article
in English
| MEDLINE | ID: mdl-17363187
4.
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine
; 2(8): 825-30, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26425688
5.
Delayed Chylothorax Following Blunt Chest Trauma.
Eur J Trauma Emerg Surg
; 36(1): 76-80, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-26815574
6.
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
J Natl Cancer Inst
; 99(24): 1845-53, 2007 Dec 19.
Article
in English
| MEDLINE | ID: mdl-18073378
7.
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
Ann Surg
; 235(4): 493-8, 2002 Apr.
Article
in English
| MEDLINE | ID: mdl-11923604
Results
1 -
7
de 7
1
Next >
>>